Hydrogen peroxide 40% versus trichloroacetic acid 70% in the treatment of seborrheic keratosis.

Wien Med WochenschrApr 29, 2026 (epub)
Clinical ResearchDermatologyOpen access

Hanaa Samy Mohamed Othman, Osama A Hashem, Osama Elshabory et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared the efficacy and safety of hydrogen peroxide 40% (H2O2) and trichloroacetic acid 70% (TCA) in treating seborrheic keratosis in 64 patients. TCA demonstrated significantly greater efficacy, achieving complete lesion clearance in 43.8% of cases compared to 0% for H2O2 (p < 0.001).

Key findings

  • Complete lesion clearance was achieved in 43.8% of TCA-treated patients versus 0% in the H2O2 group (p < 0.001).
  • Dermoscopic clearance occurred in 56.3% of TCA patients compared to 6.3% for H2O2 (p < 0.001).
  • Patient satisfaction was significantly higher with TCA treatment (p = 0.001).
  • Mild scarring was observed in 25% of TCA-treated patients, while H2O2 showed no scarring.

Why it matters

Understanding the comparative effectiveness and safety of treatments for seborrheic keratosis is crucial for clinicians to make informed decisions about patient care, particularly in balancing efficacy with potential adverse effects.

What to keep in mind

The study's limitations include a single-center design, small sample size, short follow-up, and lack of prospective trial registration.

Source

Published in Wien Med Wochenschr. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.